跳至主要内容
临床试验/IRCT2017053034222N1
IRCT2017053034222N1招募中3 期

Effect of Calcitriol supplementation on the severity of fatty liver, inflammatory and metabolic biomarkers in patients with non-alcoholic fatty liver with different genotypes of vitamin D receptor

Ahvaz Jundishapur University of Medical Sciences0 个研究点目标入组 160 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • Age between 18- 60 years
  • Presence of NAFLD diagnosed by Fibroscan elastography
  • Increased alanine transaminase (> 40 U/L)
  • BMI below 35

排除标准

  • Alcohol consumption greater than 20 g per day
  • pregnancy; lactation
  • viral or autoimmune hepatitis
  • hereditary hemochromatosis
  • Wilson's disease
  • a1-antitripsin deficiency
  • malabsorption syndromes
  • consumption of hepatotoxic drugs
  • high doses of synthetic estrogens
  • hypothyroidism and Cushing's syndrome
  • Serum calcium greater than 10.6 mg/dl
  • history of kidney stones; renal failure
  • intake of vitamin D, vitamin E and calcium supplements

研究者

相似试验

Calcitriol supplementation in Nonalcoholic Fatty... | 临床试验